These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 7621989)
1. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Unger RH Diabetes; 1995 Aug; 44(8):863-70. PubMed ID: 7621989 [TBL] [Abstract][Full Text] [Related]
2. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Lee Y; Hirose H; Zhou YT; Esser V; McGarry JD; Unger RH Diabetes; 1997 Mar; 46(3):408-13. PubMed ID: 9032096 [TBL] [Abstract][Full Text] [Related]
4. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Lee Y; Hirose H; Ohneda M; Johnson JH; McGarry JD; Unger RH Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10878-82. PubMed ID: 7971976 [TBL] [Abstract][Full Text] [Related]
5. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961 [TBL] [Abstract][Full Text] [Related]
6. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Shimabukuro M; Zhou YT; Levi M; Unger RH Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. Milburn JL; Hirose H; Lee YH; Nagasawa Y; Ogawa A; Ohneda M; BeltrandelRio H; Newgard CB; Johnson JH; Unger RH J Biol Chem; 1995 Jan; 270(3):1295-9. PubMed ID: 7836394 [TBL] [Abstract][Full Text] [Related]
8. Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Man ZW; Zhu M; Noma Y; Toide K; Sato T; Asahi Y; Hirashima T; Mori S; Kawano K; Mizuno A; Sano T; Shima K Diabetes; 1997 Nov; 46(11):1718-24. PubMed ID: 9356017 [TBL] [Abstract][Full Text] [Related]
9. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750 [TBL] [Abstract][Full Text] [Related]
10. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Zhou YP; Berggren PO; Grill V Diabetes; 1996 May; 45(5):580-6. PubMed ID: 8621007 [TBL] [Abstract][Full Text] [Related]
11. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans. Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901 [TBL] [Abstract][Full Text] [Related]
12. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism. Zhou YP; Cockburn BN; Pugh W; Polonsky KS Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766 [TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in obesity-induced beta cell disease. Shimabukuro M; Ohneda M; Lee Y; Unger RH J Clin Invest; 1997 Jul; 100(2):290-5. PubMed ID: 9218505 [TBL] [Abstract][Full Text] [Related]
15. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Mason TM; Goh T; Tchipashvili V; Sandhu H; Gupta N; Lewis GF; Giacca A Diabetes; 1999 Mar; 48(3):524-30. PubMed ID: 10078552 [TBL] [Abstract][Full Text] [Related]
16. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404 [TBL] [Abstract][Full Text] [Related]
17. Free fatty acids-the link between obesity and insulin resistance. Boden G Endocr Pract; 2001; 7(1):44-51. PubMed ID: 11250769 [TBL] [Abstract][Full Text] [Related]
18. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats. Cai Y; Lydic TA; Turkette T; Reid GE; Olson LK Biochem Pharmacol; 2015 May; 95(1):46-57. PubMed ID: 25801003 [TBL] [Abstract][Full Text] [Related]
19. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Patanè G; Piro S; Rabuazzo AM; Anello M; Vigneri R; Purrello F Diabetes; 2000 May; 49(5):735-40. PubMed ID: 10905481 [TBL] [Abstract][Full Text] [Related]
20. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]